Follow Us:
Idoxuridine

Idoxuridine

Idoxuridine

Idoxuridine is an antiviral medication primarily used to treat superficial eye infections caused by herpes simplex virus (HSV). It works by interfering with viral DNA synthesis, thereby inhibiting viral replication and helping control the infection.

Dosage Form:
Dosage Strength:
CAS No.:
Status:
Manufacturer:
Group: Antiviral Drug
Sub Group: Anti-Herpes Virus Drug

Uses of Idoxuridine

Idoxuridine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

  • Anti-herpes virus drugs are antiviral medicines used to treat infections caused by herpes viruses, including herpes simplex virus (HSV-1 and HSV-2) and varicella-zoster virus (VZV). They are commonly prescribed for oral herpes (cold sores), genital herpes, herpes zoster (shingles), and chickenpox. These medicines help reduce viral replication, shorten the duration of outbreaks, relieve symptoms, and decrease the frequency of recurrent infections. In certain patients, they are also used for long-term suppressive therapy and prevention of herpes virus infections.

Contraindication of Idoxuridine

Idoxuridine was historically subject to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Known hypersensitivity or allergic reactions to the antiviral medicine or its ingredients.
  • Severe kidney impairment may restrict the use of certain anti-herpes medicines or require dosage adjustments.
  • Some formulations may be unsuitable for patients with specific liver or kidney disorders.
  • Certain medicines may be contraindicated during pregnancy or breastfeeding depending on the active ingredient and clinical circumstances.
  • Avoid combining specific anti-herpes medicines with interacting drugs when the combination presents a significant safety risk.

Precautions for Idoxuridine

Idoxuridine was majorly subjected to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Use these medicines under medical supervision and follow the prescribed dosage and treatment duration.
  • Assess kidney function before treatment when clinically indicated, particularly in elderly patients and those with renal impairment.
  • Maintain adequate hydration, especially when taking acyclovir or valacyclovir.
  • Inform the healthcare professional about pregnancy, breastfeeding, allergies, and existing medical conditions.
  • Monitor for adverse effects such as nausea, headache, dizziness, skin rash, and gastrointestinal discomfort.
  • Start treatment as early as possible after the appearance of symptoms for better effectiveness.
  • Avoid sexual contact during active genital herpes outbreaks, as antiviral treatment does not completely eliminate the risk of transmission.
  • These medicines control viral activity but do not eliminate herpes viruses from the body.

Drug Interactions for Idoxuridine

Potential drug interactions were historically documented when Idoxuridine was prescribed alongside certain medications. These included:

  • Immunosuppressants: Concurrent use with medicines such as cyclosporine or tacrolimus may increase the risk of kidney-related adverse effects with certain antiviral agents.
  • Nephrotoxic medicines: Drugs such as aminoglycoside antibiotics, ciclosporin, and tacrolimus may increase the risk of kidney damage.
  • Probenecid: May increase acyclovir concentrations by reducing its renal elimination.
  • Cimetidine: May affect the renal clearance of certain anti-herpes medicines.
  • Other antiviral drugs: Combining antiviral agents may require careful monitoring depending on their pharmacological properties.
  • Theophylline: Valacyclovir may increase theophylline exposure in certain circumstances, requiring clinical monitoring.

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Idoxuridine.

The Idoxuridine is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Idoxuridine.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Idoxuridine, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Idoxuridine Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Idoxuridine

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Idoxuridine Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Idoxuridine, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Idoxuridine

The export of Idoxuridine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Idoxuridine Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Idoxuridine specifications, certificates of analysis, and other supporting documents required for Idoxuridine export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Idoxuridine export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Idoxuridine regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Idoxuridine documentation, labelling, Idoxuridine manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Idoxuridine Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Idoxuridine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.